These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29806659)

  • 1. The Value of Combining Plasma D-Dimer and Endothelin-1 Levels to Predict No-Reflow After Percutaneous Coronary Intervention of ST-Segment Elevation in Acute Myocardial Infarction Patients with a Type 2 Diabetes Mellitus History.
    Gao R; Wang J; Zhang S; Yang G; Gao Z; Chen X
    Med Sci Monit; 2018 May; 24():3549-3556. PubMed ID: 29806659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients.
    Zhang H; Qiu B; Zhang Y; Cao Y; Zhang X; Wu Z; Wang S; Mei L
    Med Sci Monit; 2018 Jul; 24():4528-4535. PubMed ID: 29961077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Quisi A; Alıcı G
    J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction.
    Erkol A; Oduncu V; Turan B; Kılıçgedik A; Sırma D; Gözübüyük G; Karabay CY; Guler A; Dündar C; Tigen K; Pala S; Kırma C
    J Thromb Thrombolysis; 2014 Oct; 38(3):339-47. PubMed ID: 24407374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
    Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
    Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Dimer Level Predicts Angiographic No-Reflow Phenomenon After Percutaneous Coronary Intervention Within 2-7 Days of Symptom Onset in Patients with ST-Segment Elevation Myocardial Infarction.
    Gong X; Lei X; Huang Z; Song Y; Wang Q; Qian J; Ge J
    J Cardiovasc Transl Res; 2021 Aug; 14(4):728-734. PubMed ID: 32212039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Chen X; Meng Y; Shao M; Zhang T; Han L; Zhang W; Zhang H; Hai H; Li G
    Med Sci Monit; 2020 Jan; 26():e919300. PubMed ID: 31949123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
    Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
    Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
    Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.
    Şen Ö; Şen SB; Topuz AN; Topuz M
    Biomark Med; 2021 Oct; 15(15):1357-1366. PubMed ID: 34533051
    [No Abstract]   [Full Text] [Related]  

  • 14. The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Somuncu MU; Akgun T; Cakır MO; Akgul F; Serbest NG; Karakurt H; Can M; Demir AR
    J Atheroscler Thromb; 2019 Nov; 26(11):970-978. PubMed ID: 30996145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) combined with D-dimer for no-reflow phenomenon in patients with acute coronary syndrome after emergency of percutaneous coronary intervention.
    Diao Y; Yin M; Zhang B; Sun B
    Bioengineered; 2021 Dec; 12(1):8614-8621. PubMed ID: 34612772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
    Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Association of Circulating Neutrophil Count with No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction following Successful Primary Percutaneous Intervention.
    Tian J; Liu Y; Liu Y; Song X; Zhang M; Xu F; Yuan F; Lyu S
    Dis Markers; 2017; 2017():8458492. PubMed ID: 29379223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Kurtul A; Acikgoz SK
    Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
    Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.